Elanco Animal Health Incorporated ELAN
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 12.13% | 11.95% | 10.53% | 6.22% | 3.08% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.13% | 11.95% | 10.53% | 6.22% | 3.08% |
| Cost of Revenue | 9.09% | 10.39% | 10.12% | 5.94% | 2.48% |
| Gross Profit | 14.63% | 13.24% | 10.86% | 6.44% | 3.57% |
| SG&A Expenses | 12.12% | 11.34% | 11.51% | 8.79% | 6.53% |
| Depreciation & Amortization | 4.87% | 5.50% | 5.94% | 3.04% | -0.19% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.37% | 9.63% | 9.66% | 6.55% | 3.53% |
| Operating Income | 60.73% | 58.14% | 25.31% | 0.78% | -4.26% |
| Income Before Tax | -475.00% | -127.99% | -136.75% | -145.90% | -103.88% |
| Income Tax Expenses | 205.77% | -79.25% | -72.39% | -94.67% | -125.12% |
| Earnings from Continuing Operations | -508.33% | -145.85% | -164.88% | -168.64% | -82.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -508.33% | -145.85% | -164.88% | -168.64% | -82.44% |
| EBIT | 60.73% | 58.14% | 25.31% | 0.78% | -4.26% |
| EBITDA | 20.98% | 19.60% | 12.40% | 3.30% | 4.63% |
| EPS Basic | -507.13% | -145.71% | -164.58% | -168.18% | -82.39% |
| Normalized Basic EPS | 362.38% | 2,109.09% | 292.52% | 435.90% | 192.44% |
| EPS Diluted | -606.95% | -147.91% | -167.68% | -171.77% | -84.83% |
| Normalized Diluted EPS | 363.72% | 1,950.00% | 285.38% | 417.72% | 190.69% |
| Average Basic Shares Outstanding | 0.55% | 0.53% | 0.51% | 0.47% | 0.43% |
| Average Diluted Shares Outstanding | 1.25% | 0.72% | 0.73% | 0.53% | 0.49% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |